NL-OMON33162撤回不适用
European CURE AF study, Concomitant Uitlization of Radiofrequency Energy for Atrail Fibrillation - European CURE AF study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 发起方
- Medtronic
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •1 Documented history of AF
- •2 Concomitant indication (other than AF) for open-heart surgery
- •3 Able to take the anticoagulant warfarin
- •4 Greater than or equal to 18 years of age;
- •5 Able and willing to comply with study requirements by signing a Patient Informed Consent form.
排除标准
- •1 NYHA functional class = IV,
- •2 Left ventricular ejection fraction < 30%,
- •3 Left atrial diameter > 7.0 cm,
- •4 Need for emergent cardiac surgery (i.e. cardiogenic shock) or redo open heart surgery,
- •5 Previous atrial ablation, AV-nodal ablation, or surgical Maze procedure,
- •6 Pregnancy or desire to be pregnant within 12-months of the study treatment.
研究者
相似试验
招募中
不适用
Multicenter European prospective study on the efficacy and safety of the Focal C2 CryoBalloon Ablation System in patients with Barrett*s Esophagus-related neoplasiaNL-OMON50590Sint Antonius Ziekenhuis42
招募中
不适用
Efficacy and safety of focal cryoballoon ablation for patients with dysplastic Barrett's esophagusNL-OMON25207St. Antonius Hospital, Nieuwegein107
进行中（未招募）
1 期
A study evaluating the safety and efficacy of 19CP02 in subjects with non-Hodgkin lymphomaRelapsed/refractory B-cell non-Hodgkin lymphomaMedDRA version: 20.0Level: HLGTClassification code 10025320Term: Lymphomas non-Hodgkin's B-cellSystem Organ Class: 10005329 - Blood and lymphatic system disordersEUCTR2021-003272-13-NLCellPoint B.V.45
进行中（未招募）
1 期
A study evaluating the safety and efficacy of 19CP02 in subjects with non-Hodgkin lymphomaEUCTR2021-003272-13-BECellPoint B.V.45
进行中（未招募）
1 期
A study evaluating the safety and efficacy of GLPG5101 (19CP02) in subjects with non-Hodgkin lymphomaCTIS2022-502661-23-00Galapagos40